001 | 289798 | ||
005 | 20250509120824.0 | ||
024 | 7 | _ | |a 10.1038/s41590-024-01806-z |2 doi |
024 | 7 | _ | |a pmid:38664584 |2 pmid |
024 | 7 | _ | |a 1529-2908 |2 ISSN |
024 | 7 | _ | |a 1529-2916 |2 ISSN |
024 | 7 | _ | |a altmetric:162842153 |2 altmetric |
037 | _ | _ | |a DKFZ-2024-00877 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Nobs, Samuel P |b 0 |
245 | _ | _ | |a A microbial iron fist to fight tumors. |
260 | _ | _ | |a London |c 2024 |b Springer Nature Limited |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1714993627_13239 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a #LA:D480#LA:F220# / 2024 May;25(5):720-721 |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Elinav, Eran |0 P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c |b 1 |e Last author |u dkfz |
773 | _ | _ | |a 10.1038/s41590-024-01806-z |0 PERI:(DE-600)2026412-4 |n 5 |p 720-721 |t Nature immunology |v 25 |y 2024 |x 1529-2908 |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/289798/files/s41590-024-01806-z.pdf |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/289798/files/s41590-024-01806-z.pdf?subformat=pdfa |x pdfa |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:289798 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)725ad944da4e1ea60389fe9dbbed2c7c |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-08-28 |w ger |
915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2023-08-28 |w ger |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT IMMUNOL : 2022 |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-28 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-08-28 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-08-28 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-28 |
915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b NAT IMMUNOL : 2022 |d 2023-08-28 |
920 | 2 | _ | |0 I:(DE-He78)D480-20160331 |k D480 |l Mikrobiom und Krebs |x 0 |
920 | 1 | _ | |0 I:(DE-He78)D480-20160331 |k D480 |l Mikrobiom und Krebs |x 0 |
920 | 1 | _ | |0 I:(DE-He78)F220-20160331 |k F220 |l Mikrobiom und Krebs |x 1 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D480-20160331 |
980 | _ | _ | |a I:(DE-He78)F220-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|